June 2018 Newsletter

June 22, 2018:

Ophthalmic Surgical Volume Sees Healthy Growth in Q1-2018

Glaucoma procedures rose 6.2 percent over Q1-2017.

June 22, 2018:

Q1-2018 Ophthalmic Revenues Increase 7.3 Percent Year over Year

Companies posted revenues totaling $8.2 billion.

June 22, 2018:

Negative News Story on LASIK Expected to Curb Demand in Short Term

More than half of surgeons polled by Market Scope indicated they do not anticipate a significant impact.

June 22, 2018:

US Health Secretary Alex Azar Takes Aim at Drug Rebates

He told a Senate committee that he believes his department can end the rebates that drug manufacturers negotiate with pharmacy benefit managers.

June 22, 2018:

Allergan’s Strategic Review Keeps Eye Care in Portfolio

The drugmaker is fighting several legal battles over its Restasis patents, but it cut the product’s sales force, expecting loss of protection.

June 22, 2018:

CustomFlex is First Artificial Iris to Gain US Approval

The device is custom designed to match the patient’s natural iris color.

June 22, 2018:

Optovue Receives FDA Clearance for AngioAnalytics, First Metrics for OCT Angiography

The software allows objective monitoring of retinal and vascular changes caused by disease progression or treatment.

June 22, 2018:

Bausch + Lomb Gains FDA Approval for enVista Toric MX60T IOL

The company also announced the start of a clinical trial for the enVista trifocal.

June 22, 2018:

NuSight Medical Launches Prescription NuLids System for Treating Dry Eye

The home-use medical device is designed to stimulate and rejuvenate the meibomian glands.

June 22, 2018:

Ocutrx Gets US Patent for Oculenz AR Glasses for Retinal Defects

The headset is designed to map retinal defects and display images on sighted portions of the retina.

June 22, 2018:

Market Report: New Products Poised to Drive Glaucoma Pharma Market to $6.6 Billion by 2023

The segment has seen recent US launches of Vyzulta, Rhopressa, and preservative-free formulations.

June 22, 2018:

Market Report: OCT Market to Generate $632 Million in Revenues in 2018

The segment is expected to grow at a rate of 4.8 percent over the next five years.

June 22, 2018:

Chinese Researchers Use Lenticule from SMILE to Treat Corneal Disease

The work was led by Zhou Xingtao at Fudan University.

June 22, 2018:

Coherus, MeiraGTX Lead Fundraising with Rounds of $75 Million

Other companies raised $34.2 million, bringing the total for the past month to $184.2 million.

June 22, 2018:

NASA Sends Heidelberg Spectralis with OCT2 Module to Space Station

The next-generation device will be installed in late 2018.

June 22, 2018:

Newcastle University Scientists Create First Ever 3D-Printed Human Corneas

The technique could be used to ensure an unlimited supply of corneas, the university said.

June 22, 2018:

Allergan’s Bimatoprost SR Demonstrates Noninferiority to Timolol in Phase III Study

The company plans to file an NDA in the US in the second half of 2019.

June 22, 2018:

Market Scope Weekly Polls

June 22, 2018:

June 2018 News Briefs

Social media